Abbott, Dexcom settle glucose monitoring-related patent dispute at UPC
MLex Summary: The Unified Patent Court's Nordic-Baltic division has declared the proceedings between Abbott Diabetes Care and Dexcom closed. Both parties asked to withdraw their respective claims, infringement action and counterclaim for...To view the full article, register now.
Already a subscriber? Click here to view full article